Percutaneous closure of patent foramen ovale for refractory hypoxemia after HeartMate II left ventricular assist device placement

Navin K. Kapur; John V. Conte; Jon R. Resar

Percutaneous closure of patent foramen ovale for refractory hypoxemia after HeartMate II left ventricular assist device placement

Navin K. Kapur
, John V. Conte
, Jon R. Resar

Department of Surgery

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

The incidence of probe-patent foramen ovale (PFO) at autopsy is approximately 27% with slit widths ranging from 1 mm to 19 mm (mean 4.9 mm) in diameter. In patients with end-stage heart failure requiring mechanical support, implantation of a left ventricular assist device (LVAD) abruptly decreases diastolic filling pressures and can cause right-to-left shunting with profound systemic hypoxemia. In this report, we describe the first successful PFO closure for refractory hypoxemia after implantation of an axial flow Heartmate II LVAD (Thoratec Corp., Pleasanton, California).

Original language	English (US)
Pages (from-to)	E268-E270
Journal	Journal of Invasive Cardiology
Volume	19
Issue number	9
State	Published - Sep 2007

All Science Journal Classification (ASJC) codes

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Cite this

@article{64d0ae9c272f421ab5c5dfb0b856560c,

title = "Percutaneous closure of patent foramen ovale for refractory hypoxemia after HeartMate II left ventricular assist device placement",

abstract = "The incidence of probe-patent foramen ovale (PFO) at autopsy is approximately 27\% with slit widths ranging from 1 mm to 19 mm (mean 4.9 mm) in diameter. In patients with end-stage heart failure requiring mechanical support, implantation of a left ventricular assist device (LVAD) abruptly decreases diastolic filling pressures and can cause right-to-left shunting with profound systemic hypoxemia. In this report, we describe the first successful PFO closure for refractory hypoxemia after implantation of an axial flow Heartmate II LVAD (Thoratec Corp., Pleasanton, California).",

author = "Kapur, \{Navin K.\} and Conte, \{John V.\} and Resar, \{Jon R.\}",

note = "Funding Information: The authors thank Dr M. Lock and G. Mellau for help with the FTIR measurements, Dr Th. Klaus with some millimetre wave measurements and Dr B. P. Winnewisser for many helpful discussions during the analysis of the data and for critically reading the manuscript. W. Jabs thanks the Studienstiftung des deutschen Volkes for a scholarship, the members of the Cologne submillimetre wave laboratory for their friendly collaboration, and Professor J. Koput for many discussions about ab initio calculations. The work in GieDen was supported in part by the Deutsche Forschungsge-meinschaft and Fonds der Chemischen Industrie, while the work in Cologne was supported in part by the Deutsche Forschungsgemeinschaft via Grant SFB 30 1 and special funding from the Science Ministry of the Land Nordrhein-Westfalen.",

year = "2007",

month = sep,

language = "English (US)",

volume = "19",

pages = "E268--E270",

journal = "Journal of Invasive Cardiology",

issn = "1042-3931",

publisher = "Cliggott Publishing Co.",

number = "9",

}

TY - JOUR

T1 - Percutaneous closure of patent foramen ovale for refractory hypoxemia after HeartMate II left ventricular assist device placement

AU - Kapur, Navin K.

AU - Conte, John V.

AU - Resar, Jon R.

N1 - Funding Information: The authors thank Dr M. Lock and G. Mellau for help with the FTIR measurements, Dr Th. Klaus with some millimetre wave measurements and Dr B. P. Winnewisser for many helpful discussions during the analysis of the data and for critically reading the manuscript. W. Jabs thanks the Studienstiftung des deutschen Volkes for a scholarship, the members of the Cologne submillimetre wave laboratory for their friendly collaboration, and Professor J. Koput for many discussions about ab initio calculations. The work in GieDen was supported in part by the Deutsche Forschungsge-meinschaft and Fonds der Chemischen Industrie, while the work in Cologne was supported in part by the Deutsche Forschungsgemeinschaft via Grant SFB 30 1 and special funding from the Science Ministry of the Land Nordrhein-Westfalen.

PY - 2007/9

Y1 - 2007/9

N2 - The incidence of probe-patent foramen ovale (PFO) at autopsy is approximately 27% with slit widths ranging from 1 mm to 19 mm (mean 4.9 mm) in diameter. In patients with end-stage heart failure requiring mechanical support, implantation of a left ventricular assist device (LVAD) abruptly decreases diastolic filling pressures and can cause right-to-left shunting with profound systemic hypoxemia. In this report, we describe the first successful PFO closure for refractory hypoxemia after implantation of an axial flow Heartmate II LVAD (Thoratec Corp., Pleasanton, California).

AB - The incidence of probe-patent foramen ovale (PFO) at autopsy is approximately 27% with slit widths ranging from 1 mm to 19 mm (mean 4.9 mm) in diameter. In patients with end-stage heart failure requiring mechanical support, implantation of a left ventricular assist device (LVAD) abruptly decreases diastolic filling pressures and can cause right-to-left shunting with profound systemic hypoxemia. In this report, we describe the first successful PFO closure for refractory hypoxemia after implantation of an axial flow Heartmate II LVAD (Thoratec Corp., Pleasanton, California).

UR - https://www.scopus.com/pages/publications/34548547064

UR - https://www.scopus.com/pages/publications/34548547064#tab=citedBy

M3 - Article

C2 - 17827518

AN - SCOPUS:34548547064

SN - 1042-3931

VL - 19

SP - E268-E270

JO - Journal of Invasive Cardiology

JF - Journal of Invasive Cardiology

IS - 9

ER -

Percutaneous closure of patent foramen ovale for refractory hypoxemia after HeartMate II left ventricular assist device placement

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this